Release Date: 26/07/12 08:28 Summary: Selective Share Buy Back Concluded Price Sensitive: No Download Document 326.72KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%